|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Satsuma Pharmaceuticals, Inc. (STSA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
31,530,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a therapeutic product for the acute treatment of migraine. Co.'s product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. Co.'s development plan for STS101 included a completed Phase 1 trial; a Phase 3 efficacy trial (the SUMMIT trial), which is ongoing; and continuation of the open-label, Phase 3 long-term safety trial of STS101 (the ASCEND trial).
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
52,530,894 |
59,120,894 |
Total Buy Value |
$0 |
$0 |
$47,803,114 |
$52,304,126 |
Total People Bought |
0 |
0 |
2 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
6 |
Total Shares Sold |
0 |
0 |
0 |
3,250,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$2,294,500 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Commodore Capital Lp |
10% Owner |
|
2021-10-19 |
4 |
B |
$5.07 |
$444,031 |
I/I |
87,580 |
3,458,535 |
1.5 |
- |
|
Commodore Capital Lp |
10% Owner |
|
2021-10-18 |
4 |
B |
$4.87 |
$176,265 |
I/I |
36,194 |
3,370,955 |
1.5 |
- |
|
Commodore Capital Lp |
10% Owner |
|
2021-10-15 |
4 |
B |
$4.83 |
$608,580 |
I/I |
126,000 |
3,334,761 |
1.5 |
- |
|
Commodore Capital Lp |
10% Owner |
|
2021-10-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,208,761 |
|
- |
|
Shah Rajeev M. |
Director |
|
2021-02-26 |
4 |
B |
$5.68 |
$6,999,998 |
I/I |
1,232,394 |
5,155,854 |
2.25 |
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-09-01 |
4 |
AS |
$22.21 |
$22,210 |
D/D |
(1,000) |
20,212 |
|
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-09-01 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
21,212 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-09-01 |
4 |
AS |
$22.19 |
$16,645 |
D/D |
(750) |
0 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-09-01 |
4 |
OE |
$4.56 |
$3,420 |
D/D |
750 |
750 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-08-05 |
4 |
AS |
$25.00 |
$25,000 |
D/D |
(1,000) |
0 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-08-05 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
1,000 |
|
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-08-03 |
4 |
AS |
$22.85 |
$22,906 |
D/D |
(1,000) |
20,212 |
|
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-08-03 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
20,412 |
|
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-07-01 |
4 |
AS |
$25.69 |
$26,683 |
D/D |
(1,000) |
20,212 |
|
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-07-01 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
20,312 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-07-01 |
4 |
AS |
$25.63 |
$26,654 |
D/D |
(1,000) |
0 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-07-01 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
306 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-06-23 |
4 |
AS |
$35.23 |
$74,512 |
D/D |
(2,115) |
0 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-06-23 |
4 |
OE |
$1.04 |
$2,200 |
D/D |
2,115 |
2,115 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-06-01 |
4 |
AS |
$25.32 |
$25,324 |
D/D |
(1,000) |
0 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-06-01 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
1,000 |
|
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-06-01 |
4 |
AS |
$25.26 |
$25,257 |
D/D |
(1,000) |
20,212 |
|
- |
|
Albrecht Detlef |
Chief Medical Officer |
|
2020-06-01 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
21,212 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-05-20 |
4 |
AS |
$25.00 |
$50,000 |
D/D |
(2,000) |
0 |
|
- |
|
Oneil Thomas P. |
Chief Financial Officer |
|
2020-05-20 |
4 |
OE |
$4.56 |
$9,120 |
D/D |
2,000 |
2,000 |
|
- |
|
74 Records found
|
|
Page 2 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|